If you observe any of the following, you must discard the vial
FDA APPROVES HIGH-DOSE WEGOVY March 2026 The new 7.2 mg dose is triple the previous highest dose of 2.4 mg The issue: Average weight loss with the highest dose of Wegovy is 13% to 16%, while its main competitor, Zepbound, has a mean weight loss of 20% to 22% at its highest dose Why this matters: A study comparing Wegovy doses of 2.4 mg and 7.2 mg found that the higher dose caused more weight loss, but also more gastrointestinal side effects and dysaesthesia
This example is not a one-size-fits-all plan- its simply meant to show the types of foods to prioritize while following a GLP-1 diet plan
An aggressive pricing strategy using Most Favored Nation (MFN) concepts and trade pressure to push manufacturers to offer U.S
Curious to see how this will translate into real-world use and future trial designs
Wegovy (semaglutide for weight management, titrated up to 2.4 mg weekly) is supplied as a pre-filled, single-dose pen injector designed for subcutaneous administration